Verily
Precision-health AI platform spun out of Alphabet/Google X — runs the Verily Pre clinical-research platform and Onduo virtual-care services
Healthcare
📍 Dallas, TX
Founded 2015
Current Valuation
$5.0B
as of 2026-Q1
UNICORN
Verily (formerly Google Life Sciences, renamed Verily in December 2015) is a precision-health AI company that began as a research unit inside Google X and was spun into an Alphabet subsidiary in 2015 under founding CEO Andrew Conrad. Stephen Gillett (ex-Symantec / Best Buy) took over as CEO in 2023. In March 2026 the company raised a $300M strategic round led by Series X Capital with participation from Alphabet, UCHealth, the University of Colorado Anschutz, and others — a recapitalization that left Alphabet as a significant minority (no longer controlling) investor, effectively spinning Verily out as a stand-alone company. Headquartered in Dallas, TX since August 2024 (moved from South San Francisco). Operates the Verily Pre clinical-research platform, Onduo virtual chronic-care, Project Baseline, and Liftware; recently signed partnerships with Samsung Galaxy Watch and Salesforce Agentforce Health. 2022 revenue of $559M against a $568M operating loss; total raised across Series A-C (Silver Lake, Temasek, SoftBank) plus the 2026 recap is ~$3.3B. Valuation reportedly written down ~80% from 2022 peak (~$23B) per The Information and Business Insider, putting the post-recap value in the $4-5B range.
Company Profile
Est. Revenue
$559M (2022-Q4)
Growth
Restructuring — revenue $559M (2022) with $568M operating loss; post-2026 recap is a relaunch under Series X Capital
Last Round
Strategic recapitalization — $300M (Mar 2026) · Lead: Series X Capital
IPO Status
no imminent plans
Founders & Key People
Andrew Conrad
Investors
Series X Capital · Alphabet (minority post-2026) · UCHealth · University of Colorado Anschutz · Silver Lake · Temasek · SoftBank Vision Fund
Products
- Verily Pre Platform (precision-health AI for life-sciences research)
- Onduo (virtual chronic-disease care)
- Liftware (assistive eating utensils)
- Project Baseline (longitudinal health study)
Competitors
Tempus AI · Flatiron Health (Roche) · Komodo Health · Truveta · OneStudyTeam (CRO infrastructure) · Iqvia
HealthcareAIPrecision MedicineAlphabetDecacorn (peak)Recapitalized
Private-company numbers are not real-time. Reflects publicly disclosed valuations from press releases, news reports, and tender offers as of 2026-Q1. Refreshed quarterly.